Sunday, August 19, 2018
Expert Column

Expert Column

Here the industry leaders, policymakers, guiding lights from academia and sector experts present their individual or collective viewpoints on host of issues. This column is dedicated to their experiences with various aspects of  the bioscience landscape.

Face to Face

“India will be Cepheid’s first manufacturing site outside US & Europe”

225
In an exclusive face to face interaction with the BioVoice, Mr Peter Farrell, Executive Vice President, Cepheid, and Mr Jai Shankar Krishnan, President & CEO, Danaher India shared the details about their companies' journey in India, TB elimination efforts and manufacturing plans...……..

Chat with BioVoice

“Categorization into phytopharma will encourage use of herbal drugs”

360
Mentioned Mr Amit Sharma, Director, Sanat Products in an exclusive interaction with the BioVoice where he shared details on the company's activities, regulations, outlook and much more...……………..